Mink Therapeutics Inc
NASDAQ:INKT
Mink Therapeutics Inc
NASDAQ:INKT
Price:
11.04
USD
-3.75%
Market Closed
Market Cap:
$51.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Deoleo SA
MAD:OLE
|
ES |
|
T
|
Tulikivi Oyj
OMXH:TULAV
|
FI |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
P
|
Petroneft Resources PLC
F:P8ET
|
IE |
|
Power Grid Corporation of India Ltd
NSE:POWERGRID
|
IN |
|
Future Battery Minerals Ltd
ASX:FBM
|
AU |
|
A
|
Adevinta ASA
OTC:ADEVF
|
NO |
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
IN |
|
R Systems International Ltd
NSE:RSYSTEMS
|
IN |
|
Solar Alliance Energy Inc
XTSX:SOLR
|
CA |
|
LCI Industries
NYSE:LCII
|
US |
Cash Flow Statement
Cash Flow Statement
Mink Therapeutics Inc
Mink Therapeutics Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(18)
|
(32)
|
(30)
|
(34)
|
(34)
|
(26)
|
(28)
|
(26)
|
(26)
|
(25)
|
(22)
|
(21)
|
(17)
|
(14)
|
(11)
|
(10)
|
(11)
|
(12)
|
(12)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
3
|
|
| Other Non-Cash Items |
8
|
18
|
14
|
14
|
10
|
0
|
0
|
0
|
3
|
3
|
4
|
3
|
3
|
1
|
1
|
1
|
2
|
4
|
3
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
(2)
|
4
|
7
|
10
|
9
|
9
|
6
|
4
|
4
|
3
|
3
|
2
|
2
|
0
|
0
|
2
|
3
|
3
|
|
| Cash from Operating Activities |
(12)
N/A
|
(15)
-29%
|
(13)
+17%
|
(13)
+0%
|
(14)
-9%
|
(16)
-15%
|
(19)
-17%
|
(19)
-1%
|
(19)
+2%
|
(17)
+8%
|
(16)
+8%
|
(14)
+12%
|
(12)
+13%
|
(11)
+10%
|
(10)
+12%
|
(8)
+13%
|
(8)
+9%
|
(6)
+27%
|
(6)
-6%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-79%
|
(0)
N/A
|
(0)
+16%
|
(0)
+19%
|
(0)
+29%
|
(0)
-108%
|
(0)
-4%
|
(0)
+8%
|
(0)
+17%
|
(0)
+63%
|
(0)
+14%
|
(0)
+63%
|
(0)
+85%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
40
|
40
|
40
|
40
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
6
|
6
|
6
|
6
|
0
|
14
|
15
|
|
| Net Issuance of Debt |
13
|
15
|
9
|
7
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
13
N/A
|
15
+22%
|
49
+221%
|
47
-5%
|
42
-10%
|
40
-7%
|
(0)
N/A
|
(0)
-206%
|
(0)
+16%
|
(0)
N/A
|
(0)
+1%
|
5
N/A
|
11
+119%
|
11
+0%
|
11
0%
|
6
-46%
|
0
-100%
|
14
+171 378%
|
15
+9%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
0
N/A
|
(1)
N/A
|
36
N/A
|
34
-6%
|
28
-17%
|
23
-17%
|
(19)
N/A
|
(20)
-3%
|
(19)
+3%
|
(18)
+8%
|
(16)
+8%
|
(9)
+44%
|
(1)
+86%
|
(0)
+95%
|
1
N/A
|
(3)
N/A
|
(8)
-196%
|
8
N/A
|
9
+10%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(12)
N/A
|
(16)
-30%
|
(13)
+17%
|
(13)
+0%
|
(14)
-9%
|
(16)
-15%
|
(19)
-18%
|
(19)
-1%
|
(19)
+3%
|
(17)
+8%
|
(16)
+9%
|
(14)
+12%
|
(12)
+14%
|
(11)
+10%
|
(10)
+12%
|
(8)
+13%
|
(8)
+9%
|
(6)
+27%
|
(6)
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
